February 9, 2024 |
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Attention: Chris Edwards
Re: | Moleculin Biotech, Inc. |
Registration Statement on Form S-1 |
Registration No. 333-276851 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Moleculin Biotech, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 P.M. (Eastern Time) on February 12, 2024, or as soon thereafter as possible on such date.
Very truly yours,
Moleculin Biotech, Inc.
By: /s/ Jonathan Foster Name: Jonathan Foster Title: Chief Financial Officer |